Zyflamend induces apoptosis in pancreatic cancer cells via modulation of the JNK pathway.

Dexter L PuckettMohammed AlquraishiDina AlaniSamah ChahedDallas DonohoeBrynn VoyJay WhelanAhmed Bettaieb

Published in: Cell communication and signaling : CCS (2020)

The current study identifies Zyflamend as a potential novel adjuvant in the treatment of pancreatic cancer via modulation of the JNK pathway. Video abstract.

Keyphrases

signaling pathway
cell death
induced apoptosis
early stage
risk assessment
climate change
combination therapy
endoplasmic reticulum stress
smoking cessation